Cargando…

The Two-Faced Cytokine IL-6 in Host Defense and Diseases

Interleukein-6 (IL-6), is produced locally from infectious or injured lesions and is delivered to the whole body via the blood stream, promptly activating the host defense system to perform diverse functions. However, excessive or sustained production of IL-6 is involved in various diseases. In dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Narazaki, Masashi, Kishimoto, Tadamitsu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274717/ https://www.ncbi.nlm.nih.gov/pubmed/30423923 http://dx.doi.org/10.3390/ijms19113528

Ejemplares similares

Historical overview of the interleukin-6 family cytokine
por: Kang, Sujin, et al.
Publicado: (2020)

Correction: Historical overview of the interleukin-6 family cytokine
por: Kang, Sujin, et al.
Publicado: (2020)

Interleukin-6: discovery of a pleiotropic cytokine
por: Kishimoto, Tadamitsu
Publicado: (2006)

Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms
por: Kang, Sujin, et al.
Publicado: (2021)

The paradigm of IL-6: from basic science to medicine
por: Naka, Tetsuji, et al.
Publicado: (2002)

Differential Effects of IL-2 and IL-6 on the Development of Three Distinct Precursor T-Cell Populations in the Thymus
por: Nakano, Naoko, et al.
Publicado: (1990)

The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
por: Shima, Yoshihito, et al.
Publicado: (2010)

Targeting Interleukin-6: All the Way to Treat Autoimmune and Inflammatory Diseases
por: Tanaka, Toshio, et al.
Publicado: (2012)

Translating IL-6 biology into effective treatments
por: Choy, Ernest H., et al.
Publicado: (2020)

IL-1β Processing in Host Defense: Beyond the Inflammasomes
por: Netea, Mihai G., et al.
Publicado: (2010)

Signal Transducer and Activator of Transcription (Stat)-Induced Stat Inhibitor 1 (Ssi-1)/Suppressor of Cytokine Signaling 1 (Socs1) Inhibits Insulin Signal Transduction Pathway through Modulating Insulin Receptor Substrate 1 (Irs-1) Phosphorylation
por: Kawazoe, Yoshinori, et al.
Publicado: (2001)

Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis
por: Mihara, Masahiko, et al.
Publicado: (2011)

346 Clinical Effects of Tocilizumab, a Humanized Anti-interleukin-6 Receptor Antibody, on Patients with Autoimmune and Allergic Diseases
por: Tanaka, Toshio, et al.
Publicado: (2012)

IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome
por: Kang, Sujin, et al.
Publicado: (2020)

Reply to Cheng et al.: COVID-19 induces lower extent of cytokines, but damages vascular endothelium by IL-6 signaling
por: Kang, Sujin, et al.
Publicado: (2021)

Type II Cytokines Impair Host Defense Against Intracellular Fungal Pathogen by Amplifying Macrophage Generation of IL-33
por: Verma, Akash, et al.
Publicado: (2014)

The Inflammasome in Host Defense
por: Chen, Gang, et al.
Publicado: (2009)

Hepcidin and Host Defense against Infectious Diseases
por: Michels, Kathryn, et al.
Publicado: (2015)

Cytokines IL-17 and IL-22 in the host response to infection
por: Valeri, Maria, et al.
Publicado: (2016)

Right on the Nose: IL-17C and Nasal Host Defense
por: Zemke, Anna C., et al.
Publicado: (2020)

Study of active controlled tocilizumab monotherapy for rheumatoid arthritis patients with an inadequate response to methotrexate (SATORI): significant reduction in disease activity and serum vascular endothelial growth factor by IL-6 receptor inhibition therapy
por: Nishimoto, Norihiro, et al.
Publicado: (2008)

Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae
por: Happel, Kyle I., et al.
Publicado: (2005)

The in vivo Anti‐tumor Effect of Human Recombinant Interleukin‐6
por: Kitahara, Misa, et al.
Publicado: (1990)

Salivary mucins in host defense and disease prevention
por: Frenkel, Erica Shapiro, et al.
Publicado: (2015)

Effects of Terpenes on the Osteoarthritis Cytokine Profile by Modulation of IL-6: Double Face versus Dark Knight?
por: Farì, Giacomo, et al.
Publicado: (2023)

Host-Defense Activities of Cyclotides
por: Craik, David J.
Publicado: (2012)

IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis
por: Browning, Landon, et al.
Publicado: (2018)

NLRP6 in host defense and intestinal inflammation
por: Venuprasad, K., et al.
Publicado: (2021)

Current Knowledge of IL-6 Cytokine Family Members in Acute and Chronic Kidney Disease
por: Magno, Aaron L., et al.
Publicado: (2019)

The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease
por: Bastian, David, et al.
Publicado: (2019)

Joint disease caused by defective gp130-mediated STAT signaling
por: Naka, Tetsuji, et al.
Publicado: (2002)

The emerging role of Arid5a in cancer: A new target for tumors
por: Nyati, Kishan Kumar, et al.
Publicado: (2022)

Participation of the IL-10RB Related Cytokines, IL-22 and IFN-λ in Defense of the Airway Mucosal Barrier
por: Ahn, Danielle, et al.
Publicado: (2020)

IL-36 cytokines in autoimmunity and inflammatory disease
por: Ding, Liping, et al.
Publicado: (2017)

IL-17 Cytokines and Chronic Lung Diseases
por: Ritzmann, Felix, et al.
Publicado: (2022)

New perspectives in cancer immunotherapy: targeting IL-6 cytokine family
por: Soler, Maria Florencia, et al.
Publicado: (2023)

IL-26, a Cytokine With Roles in Extracellular DNA-Induced Inflammation and Microbial Defense
por: Larochette, Vincent, et al.
Publicado: (2019)

The Two-Faced Role of SIRT6 in Cancer
por: Fiorentino, Francesco, et al.
Publicado: (2021)

Anti-IL-6 Receptor Antibody Causes Less Promotion of Tuberculosis Infection than Anti-TNF-α Antibody in Mice
por: Okada, Masaji, et al.
Publicado: (2011)

Oncolytic Activities of Host Defense Peptides
por: Al-Benna, Sammy, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_lnlgkd1300abrrfc2tem7cdopu